The European Medicines Evaluation Agency (EMEA) has released recommendations for improving information for patients. The document was drafted together with stakeholders groups and covers three main areas:
information provision adapted to patients’ needs
developing appropriate communication tools
increasing public awareness on drugs and EMEA’s roles
EPHA has been involved in developing the recommendations on pharmacovigilance.
Patient information has been a key political issue and the recommendations are EMEA’s first response to the G10 report and the Competitiveness Council meeting of September 2003.
The deadline for comments to be sent by email is 15 July 2004.
